Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network   Report issue

Foundation Phase 2 Phase 4
Founded: Montreal Canada (2015)

Organization Overview

First Clinical Trial
2020
NCT04153760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network